Literature DB >> 29550897

Asymptomatic Renal Stones-to Treat or Not to Treat.

Necole M Streeper1.   

Abstract

PURPOSE OF REVIEW: There are no current guidelines on the optimal management of asymptomatic renal stones. This review summarizes the current literature, focusing on more recent studies that have been done to grow the body of evidence on this topic. RECENT
FINDINGS: Recent studies have found that stone size is a significant predictor of need for future surgical intervention, with > 7 mm for pediatric population and > 4 mm for residual fragments after both PNL and ureteroscopy (URS). The role of URS has been better defined with a recent RCT concluding that URS and SWL had comparable outcomes for an asymptomatic lower pole stone < 1 cm. The treatment decision for asymptomatic renal stones should take into consideration a variety of relevant patient and stone factors; however, ultimately, a shared decision-making approach should be used. In the properly counseled patient, active surveillance or prophylactic surgical intervention may be appropriate.

Entities:  

Keywords:  Asymptomatic; Observation; Renal stones; Residual fragments; Treatment

Mesh:

Year:  2018        PMID: 29550897     DOI: 10.1007/s11934-018-0782-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  25 in total

1.  Urologic diseases in America project: urolithiasis.

Authors:  Margaret S Pearle; Elizabeth A Calhoun; Gary C Curhan
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

2.  What happens to asymptomatic lower pole kidney stones smaller than 10 mm in children during watchful waiting?

Authors:  Onur Telli; Nurullah Hamidi; Uygar Bagci; Arif Demirbas; Ahmet Metin Hascicek; Tarkan Soygur; Berk Burgu
Journal:  Pediatr Nephrol       Date:  2017-01-09       Impact factor: 3.714

3.  Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I.

Authors:  Dean Assimos; Amy Krambeck; Nicole L Miller; Manoj Monga; M Hassan Murad; Caleb P Nelson; Kenneth T Pace; Vernon M Pais; Margaret S Pearle; Glenn M Preminger; Hassan Razvi; Ojas Shah; Brian R Matlaga
Journal:  J Urol       Date:  2016-05-27       Impact factor: 7.450

4.  Outcomes of long-term follow-up of patients with conservative management of asymptomatic renal calculi.

Authors:  Li-Tsa Koh; Foo-Cheong Ng; Kok-Kit Ng
Journal:  BJU Int       Date:  2011-08-18       Impact factor: 5.588

5.  The natural history of nonobstructing asymptomatic renal stones managed with active surveillance.

Authors:  Benjamin M Dropkin; Rachel A Moses; Devang Sharma; Vernon M Pais
Journal:  J Urol       Date:  2014-11-15       Impact factor: 7.450

6.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

7.  Shared decision making: why do patients choose ureteroscopy?

Authors:  Mohamed Omar; Sarah Tarplin; Robert Brown; Sri Sivalingam; Manoj Monga
Journal:  Urolithiasis       Date:  2015-07-25       Impact factor: 3.436

8.  Patient decision making for asymptomatic renal calculi: balancing benefit and risk.

Authors:  Carl Sarkissian; Mark Noble; Jianbo Li; Manoj Monga
Journal:  Urology       Date:  2013-02       Impact factor: 2.649

9.  Prevalence of urolithiasis in asymptomatic adults: objective determination using low dose noncontrast computerized tomography.

Authors:  Cody J Boyce; Perry J Pickhardt; Edward M Lawrence; David H Kim; Richard J Bruce
Journal:  J Urol       Date:  2010-01-21       Impact factor: 7.450

Review 10.  Management options for lower pole renal calculi.

Authors:  Jay D Raman; Margaret S Pearle
Journal:  Curr Opin Urol       Date:  2008-03       Impact factor: 2.309

View more
  1 in total

1.  Urolithiasis in Germany: Trends from the National DRG Database.

Authors:  Hendrik Heers; David Stay; Thomas Wiesmann; Rainer Hofmann
Journal:  Urol Int       Date:  2021-12-09       Impact factor: 1.934

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.